Founded midway through the seventies in Castel Bolognese (Ravenna), Comercer is currently a world leader in the field of nuclear medicine, specialising in radiopharmaceutical management, processing, and metering systems.
Its machinery is used in laboratories throughout the world: from pharmaceutical multinationals and hospitals, through to the research centres at Harvard and Stanford, as well as being used for research into Parkinson’s and stem cells.
Most of Comercer’s staff are based at its headquarters in Italy but it also has branches in Miami and Mumbai and will soon be opening branches in China and Germany. It exports 90% of its production to 100 countries and its R&D investment is one of the company’s strengths in achieving growth in a very specific sector in which Italian exports are unrivalled.
“We have believed in our country and projected it abroad. We have taken risks at a difficult time for Italy, aware that keeping the production process under the Made in Italy label is synonymous with quality and pays dividends in time, especially in international markets.”Alessia Zanelli, CEO of Comecer
In current times, difficulties in accessing credit have been the main obstacle to the growth plans of Italian businesses, especially SMEs. The intervention of SACE in these cases can facilitate access to liquidity in concrete terms for many companies and it is for this reason that, for many years, the Group has been collaborating with major banks supporting businesses in their development projects abroad.
Comercer has also benefited from the SACE guarantee of €1.5 million funding destined to support R&D costs for new products, the expenses related to taking part in trade fairs, advertising costs and investments in foreign branches.
With the Guarantee for the internationalisation of SMEs SACE supports small and medium sized enterprises in their development projects abroad.
Find out how Comecer, together with SACE, managed to safely invest in Italy and abroad